Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income ▴	Net margin	Return on equity	Revenue growth	Diluted EPS
TPST	Tempest Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.26M	n/a	-393.9%	n/a	-$6.33
CLNN	Clene Inc. Manufacturing · Year ended 2025-12-31 · USD	$200.0K	-$26.17M	n/m	n/a	-41.5%	n/a
APVO	Aptevo Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$25.97M	n/a	-149.4%	n/a	-$87.27
TVTX	Travere Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$490.73M	-$25.55M	-5.2%	-22.2%	110.5%	-$0.29
LBRX	LB Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$25.20M	n/a	-8.4%	n/a	-$3.13
ZVSA	ZyVersa Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$24.95M	n/a	n/a	n/a	-$4.18
LIFD	Lftd Partners Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.92M	-$24.86M	-67.3%	-196.8%	-1.1%	-$1.68
CTOR	Citius Oncology, Inc. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$24.76M	n/a	-55.2%	n/a	-$0.34
ASBP	Aspire Biopharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.2K	-$24.48M	n/m	n/a	n/a	-$16.38
TOVX	Theriva Biologics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$23.74M	n/a	-154.3%	n/a	-$2.08
MIRM	Mirum Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$521.31M	-$23.36M	-4.5%	-7.4%	54.7%	-$0.47
VERU	Veru Inc. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$22.73M	n/a	-124.0%	n/a	n/a
LGVN	Longeveron Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.20M	-$22.70M	n/m	-400.1%	-49.9%	-$1.29
CING	Cingulate Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.45M	n/a	-894.8%	n/a	-$4.44
EQ	Equillium, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.40M	n/a	-78.3%	n/a	-$0.39
MAIA	MAIA Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.40M	n/a	-942.7%	n/a	-$0.70
ACTU	Actuate Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.23M	n/a	-280.5%	n/a	-$1.06
BIVI	Biovie Inc. Manufacturing · Year ended 2026-06-30 · USD	n/a	-$22.07M	n/a	-214.9%	n/a	-$3.05
CLRB	Cellectar Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$21.79M	n/a	-255.2%	n/a	-$8.35
GOVX	GeoVax Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.49M	-$21.46M	-862.3%	-561.2%	-37.1%	n/a
COYA	Coya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.95M	-$21.23M	-267.1%	-49.3%	123.6%	-$1.27
FTH	Faeth Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$21.09M	n/a	-113.4%	n/a	-$16.72
INDP	Indaptus Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$20.85M	n/a	-661.5%	n/a	-$21.58
WHWK	Whitehawk Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.14M	-$20.60M	-288.3%	-15.1%	-72.5%	-$0.33
KTTA	Pasithea Therapeutics Corp. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$20.43M	n/a	-37.0%	n/a	-$2.91

Rows per page: 2550 100